Association for Academic SurgeryBlood transfusion is an independent predictor of morbidity and mortality after hepatectomy
Introduction
Before 1980s, the perioperative mortality rate for hepatectomy was >10%. Improvements in operative technique, perioperative and anesthetic care, and patient selection have resulted in present-day mortality rates of <2%-4% at experienced centers.1, 2, 3, 4 Improvement in technique and reduction in mortality has been demonstrated to be correlated with decrease in perioperative blood transfusion.5
Hepatectomy remains a high-risk operation with estimated transfusion rates between 20% and 30%.6, 7 Blood transfusion is associated with higher costs and increased risk of associated morbidity. Multiple recent studies have suggested worse oncologic outcomes most notably in patients with primary or metastatic malignancies leading to proposals for transfusion restrictions in patients undergoing hepatectomy.8, 9
Despite the advancements in surgical technique, more extensive liver resections may be associated with greater transfusion requirements.10 Whether blood transfusion represents an independent variable or a surrogate for more complex or extensive liver resection has not been well defined. We hypothesized an independent association between blood transfusion and postoperative morbidity and mortality in patients undergoing hepatectomy, regardless of extent of resection.
Section snippets
Patient selection criteria and outcome definitions
The present study used patient records obtained from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) public use file linked with additional clinical information available from an institutional liver resection database. The NSQIP data set is a comprehensive, national database that collects patient-level, Health Insurance Portability and Accountability Act compliant data provided by participating hospitals. The University of Virginia Institutional Review
Patient demographics and individual risk factors
Five hundred and twenty-two adult patients aged ≥18 y undergoing hepatectomy between 2006 and 2013 were included in this study. Forty-eight (9.2%) patients required a perioperative blood transfusion. The median age of patients who received blood transfusion was 61.4 y (IQR, 52.9-70.0) and was not significantly different from the median age of nontransfused patients (58.1 y [IQR, 49.9-67.8], P value = 0.184). There were no significant differences in the distributions of sex, BMI, or race between
Discussion
Blood transfusion is associated with increased risk of morbidity and mortality after hepatectomy, independent of differences in patient comorbidities and extent of resection. The negative effects of blood transfusion in morbidity and mortality models have large effect sizes and strongly significant independent results. In addition to the well-described transfusion-associated risks of lung injury and hemolytic transfusion reaction, transfusion has been associated with poor immune-modulated
Conclusions
Blood transfusion is a highly statistically significant independent predictor of morbidity and mortality after hepatectomy. Judicious use of perioperative transfusion is indicated in patients with both benign and malignant indications for liver resection.
Acknowledgment
American College of Surgeons National Surgical Quality Improvement Program and the hospitals participating in the ACS NSQIP are the source of a portion of data used herein; they have not verified and are not responsible for the statistical validity of the data analyses or the conclusions derived by the authors.
This study was supported in part by funding provided by the Institutional National Research Service Award T32 CA 163177 from the National Cancer Institute to A.N.M.
Authors' contributions:
References (38)
- et al.
Morbidity and mortality of hepatectomy for benign liver tumors
Am J Surg
(2016) - et al.
Advances in hepatectomy technique: toward zero transfusions in the modern era of liver surgery
Surgery
(2016) - et al.
Identifying variations in blood use based on hemoglobin transfusion trigger and target among hepatopancreaticobiliary surgeons
J Am Coll Surg
(2014) - et al.
Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections
Surgery
(2010) - et al.
Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity
Am J Surg
(2015) - et al.
A Cochrane systematic review and network meta-analysis comparing treatment strategies aiming to decrease blood loss during liver resection
Int J Surg
(2015) - et al.
Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery
J Gastrointest Surg
(2015) - et al.
Factors in perioperative care that determine blood loss in liver surgery
HPB (Oxford)
(2012) - et al.
Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma
J Gastrointest Surg
(2015) - et al.
Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus
J Am Coll Surg
(2013)
ACS-NSQIP has the potential to create an HPB-NSQIP option
HPB (Oxford)
Patterns of care among patients undergoing hepatic resection: a query of the National Surgical Quality Improvement Program-targeted hepatectomy database
J Surg Res
Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series
HPB (Oxford)
The role of central venous pressure and type of vascular control in blood loss during major liver resections
Am J Surg
Selective hepatic vascular exclusion and Pringle maneuver: a comparative study in liver resection
Eur J Surg Oncol
Patient blood management in Europe
Br J Anaesth
Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database
Ann Surg
Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma
Ann Surg Oncol
Postoperative management after hepatic resection
J Gastrointest Oncol
Cited by (0)
Presented in part at the 11th Annual Academic Surgical Congress, February 2-4, 2016, Jacksonville, FL.